International Day for Interventional Cardiology: A lifeline through innovation

“Major problems in the cath lab result from the smallest errors” — Don Baim, MD.

Fifty years ago, the default treatment for blocked coronary arteries was open-heart surgery, which had several risks like bleeding, infections, and blood clots. Recovery from such surgery took months and required an extended hospital stay.

Then, in Zurich in 1977, Dr. Andreas Grüntzig performed a new procedure to open blocked arteries. To restore normal blood flow in the narrowed artery, he inserted a catheter with a balloon and inflated the balloon to compress the plaque, thereby ensuring blood flow. Thus, angioplasty and Interventional Cardiology were born.

Dr. Andreas’ approach was followed by a flood of innovations, including stents that keep arteries open, minimally invasive valve replacements, and diagnostic tools that utilize imaging to evaluate the heart and blood vessels. With these developments, patients once deemed untreatable now have a far improved prognosis.

Interventional Cardiology Procedures

Interventional cardiology is a catheter-based, minimally invasive treatment for cardiovascular disease. A few of its procedures are:

• Atherectomy and Angioplasty: A device (atherectomy) or a balloon (angioplasty) is used to open blocked arteries in the heart and other parts of the body.
• Percutaneous Coronary Intervention (PCI): a blocked artery is opened using a balloon, and a stent is inserted to keep it open.
• Percutaneous Valve Repair: Repair or replace faulty heart valves through a catheter.
• Transcatheter Aortic Valve Replacement (TAVR): A diseased aortic heart valve is replaced through a catheter.
• Cardiac Catheterization: Create moving X-ray pictures of the heart to identify blockages or other issues.
• Intracoronary Imaging: Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) are used to get detailed images of arteries.

The significant advantage of these procedures is that the patients quickly resume normal activities: walking within hours and returning home the next day.

A Global Burden, a Global Response

Cardiovascular disease is the world’s number one killer, causing about 18 million deaths annually. Diabetes, obesity, high blood pressure, and smoking are the main factors causing this epidemic.

Administering clot-busting drugs or performing an emergency angioplasty to open a blocked artery within 60 minutes of the heart attack symptoms appearing, that is, within the “Golden Hour,” dramatically improves the survival rate. Interventional Cardiology makes such interventions possible.

High-income countries have well-equipped Cath labs and trained specialists, and thus, patients have access to Interventional Cardiology. But these are not available in low- and middle-income nations, which have limited resources.

The Ethical and Economic Dimensions

Interventional cardiology raises questions of accessibility, cost, and ethics.

Interventional cardiology procedures, such as advanced imaging and TAVR, are expensive. To ensure that the patients have equitable access to such procedures demands innovative financing models and funded healthcare systems.

Interventional cardiology 2025-2050

Advances in AI and robotics, bioresorbable stents, imaging (3D/4D, augmented reality), remote interventions, and personalized medicine will shape the future of IC.

1. Advanced Imaging:

Holographic displays, 3D and 4D imaging, and augmented reality will provide unprecedented clarity for IC.

2. Bioresorbable Stents:

Stents made from metals like magnesium or polymers like polylactic acid hold a clogged artery open temporarily and then dissolve or get absorbed into the body. Thus, long-term risks associated with a permanent foreign object, metallic stents, are eliminated.

3. Artificial Intelligence (AI) and Robotics:

AI will enhance imaging and improve the accuracy of diagnoses. Soon, remote intervention will be possible using Robotic procedures, which are more accurate.

4. Personalized and Precision Medicine:

Cardiac CT or coronary CT angiography (CCTA) gives detailed images of the heart and coronary arteries and thus enables non-invasive detection and assessment of coronary artery disease (CAD). Fractional flow reserve (FFR) gives a quantitative value of how much the blockage restricts blood flow to the heart muscle and thus helps doctors determine if an intervention like angioplasty or stenting is required.

Conclusion: A Celebration of Lives Saved

Advancements in artificial intelligence and imaging are making more precise and personalized interventions possible. Bioresorbable stents eliminate complications such as stent thrombosis and malapposition associated with permanent metallic stents. These improve long-term outcomes and preserve options for future interventions. Robot-assisted procedures have enhanced the accuracy of the procedure and made possible care through remote interventions.

Soon, personalized medicine, AI-driven decision-making, and minimally invasive techniques will significantly improve patient outcomes in cardiovascular diseases.

END OF ARTICLE